LEADERSHIP
Kinaset is led by a team with significant respiratory drug development experience and supported by leading scientific and clinical advisors in the field.
Robert Clarke, PhD
Chief Executive Officer / Board Member / Co-Founder
Roger Heerman, MBA
Chief Business/Operating Officer / Co-Founder
Frazer Morgan
Chief Development Officer / Co-Founder
Christopher O’Brien, MD, PhD, FCCP
Chief Medical Officer
Anesa Moyer
Vice President of Clinical Operations
Nayna Govind
Vice President, CMC
Marc Swikalus, CPA, MBA
Vice President, Finance
BOARD OF DIRECTORS
Daniel G. Welch
Chairman of the Board
Kevin Bitterman, Ph.D.
Atlas Venture
Elliot Levy, M.D.
5AM Ventures
Christoph Kocher
Gimv
Henry Stusnick
RA Capital
Daniela Begolo
EQT Life Sciences
David Lubner
Independent Director
Robert Clarke, Ph.D.
Chief Executive Officer
SCIENTIFIC ADVISORS
Ian Adcock, Ph.D.
Professor of Respiratory Cell & Molecular Biology, Imperial College
Gary Burgess M.B., ChB MMed(Int)(Stell) MFPM
Medical Consultant, GCB Clinical Consulting
Kristen Slaoui, Ph.D.
Chief Corporate Development Officer, Galderma
Dave Singh, M.D.
Professor, The University of Manchester
